LLY (STOCKS)
Eli Lilly & Co.
$929.900100
-9.569900 (-1.02%)
Prev close: $939.470000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- David A. Ricks
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $878,247.05M
- Employees
- 47,000
- P/E (TTM)
- 40.93
- P/B (TTM)
- 33.45
- Dividend Yield
- 66.31%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
12
Strong Buy
18
Buy
8
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$7.54 | $6.74 | +0.8028 | +11.92% |
|
Sep 2025 (Q3)
|
$7.02 | $5.75 | +1.2681 | +22.05% |
|
Jun 2025 (Q2)
|
$6.31 | $5.51 | +0.7993 | +14.50% |
|
Mar 2025 (Q1)
|
$3.34 | $3.05 | +0.2865 | +9.38% |
Financial Statements
| Revenues | $65.18B |
| Benefits Costs and Expenses | $39.45B |
| Cost Of Revenue | $11.05B |
| Costs And Expenses | $39.45B |
| Gross Profit | $54.13B |
| Nonoperating Income/Loss | -$571.00M |
| Operating Expenses | $28.40B |
| Selling, General, and Administrative Expenses | $11.09B |
| Other Operating Expenses | $17.30B |
| Operating Income/Loss | $25.73B |
| Income/Loss From Continuing Operations After Tax | $20.64B |
| Income/Loss From Continuing Operations Before Tax | $25.73B |
| Income Tax Expense/Benefit | $5.09B |
| Income Tax Expense/Benefit, Current | $6.80B |
| Income Tax Expense/Benefit, Deferred | -$1.71B |
| Net Income/Loss | $20.64B |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $20.64B |
| Net Income/Loss Available To Common Stockholders, Basic | $20.64B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $23.00 |
| Diluted Earnings Per Share | $22.95 |
| Basic Average Shares | 897,300,000 |
| Diluted Average Shares | 899,300,000 |
| Assets | $112.48B |
| Current Assets | $55.63B |
| Inventory | $13.74B |
| Prepaid Expenses | $14.32B |
| Other Current Assets | $27.57B |
| Noncurrent Assets | $56.85B |
| Fixed Assets | $24.68B |
| Intangible Assets | $6.52B |
| Other Non-current Assets | $25.65B |
| Liabilities | $85.94B |
| Current Liabilities | $35.23B |
| Accounts Payable | $5.38B |
| Wages | $2.38B |
| Other Current Liabilities | $27.47B |
| Noncurrent Liabilities | $50.71B |
| Equity | $26.54B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $26.54B |
| Liabilities And Equity | $112.48B |
| Net Cash Flow From Operating Activities | $16.81B |
| Net Cash Flow From Operating Activities, Continuing | $16.81B |
| Net Cash Flow From Investing Activities | -$10.97B |
| Net Cash Flow From Investing Activities, Continuing | -$10.97B |
| Net Cash Flow From Financing Activities | -$2.21B |
| Net Cash Flow From Financing Activities, Continuing | -$2.21B |
| Exchange Gains/Losses | $372.00M |
| Net Cash Flow | $4.00B |
| Net Cash Flow, Continuing | $3.63B |
| Comprehensive Income/Loss | $22.08B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $22.08B |
| Other Comprehensive Income/Loss | $22.08B |
| Other Comprehensive Income/Loss Attributable To Parent | $1.44B |